Sarcopenia, a disorder that involves the generalized loss of skeletal muscle strength and
mass, was formally recognized as a disease by its inclusion in the International …

Diabetes and sarcopenia are emerging as serious public health issues. Sarcopenia, an age-
related disorder characterized by loss of skeletal muscle mass and function, is recognized …

The progressive loss of skeletal muscle mass and concomitant reduction in contractile
strength plays a central role in frailty syndrome. Age-related neuronal impairments are …

The rapid increase in both the lifespan and proportion of older adults is accompanied by the
unprecedented rise in age-associated chronic diseases, including sarcopenia and obesity …

Background Chronic inflammatory responses have been reported to be associated with low
muscle mass and systemic immune-inflammation index (SII) is a novel indicator of …

Obesity is a growing public health problem and a well-established risk factor for chronic
disease, including cardiovascular and metabolic disease, cognitive impairment, and …

Background Declined skeletal muscle mass and function are inevitable consequences of
long‐term diabetes and bring about many adverse events. Muscle fibre atrophy and …

Sarcopenia, characterized by the insidious reduction of skeletal muscle mass and strength,
detrimentally affects the quality of life in elderly cohorts. Present therapeutic strategies are …

Background Growing evidence has increasingly validated that individuals with
diabetes/prediabetes have a higher prevalence of low skeletal muscle mass and function …

Purpose Observational studies have reported that autoimmune diseases are closely related
to sarcopenia, but the causalities of autoimmune diseases with sarcopenia have not been …